A treatment to halt the progress of multiple sclerosis could become a reality for sufferers after the launch of a major trial in Bristol.
The new drug developed in the city has been found to stop the immune system's attack on the covering of the nerve cells. Unlike other treatments the drug does not seem to prevent the immune system fighting viruses.
It has been developed by Bristol University spin-off company, Apitope, who believe it could prevent relapses and stop further degeneration as a result of the condition.
A study of how the treatment works in 40 people has now been launched and patients are being recruited for the trial.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2341
